RichardChaceMD

Ophthalmology • Portsmouth, NH

Cataract Related, Retinal Disease

Eyesight Ophthalmic Services Clear Advantage

Join to view full profile

Dr. Chace is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Chace's full profile

Already have an account?

Office
155 Borthwick Ave
Suite 200 East
Portsmouth, NH 03801
Phone+1 603-436-1773

Fax+1 603-427-0655
Is this information wrong?

Summary

Dr. Richard Chace is an ophthalmologist in Portsmouth, NH and is affiliated with multiple hospitals in the area, including Exeter Hospital, Frisbie Memorial Hospital, Portsmouth Regional Hospital, and Wentworth-Douglass Hospital. He received his medical degree from Warren Alpert Medical School of Brown University and has been in practice 38 years. He specializes in cataract related and retinal disease and is experienced in cataracts, cataract surgery, glaucoma, vitreoretinal disease, and medical retina.

Education & Training

Tufts Medical CenterResidency, Ophthalmology, 1980 - 1983
Armed Forces Institute of PathologyNo degree, Opthalmic Pathology Course, 1982
Newton-Wellesley HospitalInternship, Internal Medicine, 1979 - 1980
Colby CollegeNo degree, Lancaster Course in Opthalmology, 1980
The Warren Alpert Medical School of Brown UniversityClass of 1979
Massachusetts Institute of TechnologyB.S., 1974

Certifications & Licensure

NH State Medical License 1983 - 2025
American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012-2013

Clinical Trials

Fluocinolone Acetonide Implant Compared to Sham Injection in Patients With Diabetic Macular Edema Start of enrollment: 2007 Sep 01
Completed
Phase 3
Vascular Endothelial Growth Factor VEGF Trap-Eye:Investigation of Efficacy and Safety in Wet Age-Related Macular Degeneration(AMD) Start of enrollment: 2007 Aug 01
Completed
Phase 3
Fluocinolone Acetonide in Diabetic Macular Edema (FAME) Extension Study Start of enrollment: 2011 Apr 01
Completed
Phase 3
NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME) Start of enrollment: 2011 May 01
Completed
Phase 2
Treatment for CI-DME in Eyes With Very Good VA Study Start of enrollment: 2013 Oct 01
Completed
Phase 3
A Phase 3 Safety and Efficacy Study of Fovista® (E10030) Intravitreous Administration in Combination With Either Avastin® or Eylea® Compared to Avastin® or Eylea® Monotherapy Start of enrollment: 2014 May 01
Terminated
Phase 3
A Phase 3 Safety and Efficacy Study of Fovista® (E10030) Intravitreous Administration in Combination With Lucentis® Compared to Lucentis® Monotherapy Start of enrollment: 2013 Aug 01
Terminated
Phase 3
Ocriplasmin Research to Better Inform Treatment (ORBIT) Start of enrollment: 2014 May 01
Completed
A Retrospective Chart Review of Patients Treated With Ocriplasmin for Symptomatic VMA Start of enrollment: 2014 Aug 01
Completed
Phase 4 IOP Signals Associated With ILUVIEN® Start of enrollment: 2015 May 06
Completed
Phase 4
Join now to see all

Publications & Presentations

PubMed

9 citations
Combination verteporfin photodynamic therapy ranibizumab-dexamethasone in choroidal neovascularization due to age-related macular degeneration: results of a phase II r...
Ron P. Gallemore, Josh Wallsh, Henry L Hudson, Allen C. Ho, Richard Chace, Joel Pearlman> ;Clinical Ophthalmology. 2017 Jan 24
Association of Baseline Visual Acuity and Retinal Thickness With 1-Year Efficacy of Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema.
Wells JA, Glassman AR, Jampol LM, Aiello LP, Antoszyk AN, Baker CW, Bressler NM, Browning DJ, Connor CG, Elman MJ, Ferris FL, Friedman SM, Melia M, Pieramici DJ, Sun J...> ;JAMA Ophthalmol. 2016 Feb
Repeated intravitreous ranibizumab injections for diabetic macular edema and the risk of sustained elevation of intraocular pressure or the need for ocular hypotensive...
Bressler SB, Almukhtar T, Bhorade A, Bressler NM, Glassman AR, Huang SS, Jampol LM, Kim JE, Melia M> ;JAMA Ophthalmol. 2015 May
Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema.
Wells JA, Glassman AR, Ayala AR, Jampol LM, Aiello LP, Antoszyk AN, Arnold-Bush B, Baker CW, Bressler NM, Browning DJ, Elman MJ, Ferris FL, Friedman SM, Melia M, Piera...> ;N Engl J Med. 2015 Mar 26
Sustained delivery fluocinolone acetonide vitreous implants: long-term benefit in patients with chronic diabetic macular edema.
Cunha-Vaz J, Ashton P, Iezzi R, Campochiaro P, Dugel PU, Holz FG, Weber M, Danis RP, Kuppermann BD, Bailey C, Billman K, Kapik B, Kane F, Green K> ;Ophthalmology. 2014 Oct
Exploratory analysis of the effect of intravitreal ranibizumab or triamcinolone on worsening of diabetic retinopathy in a randomized clinical trial.
Bressler SB, Qin H, Melia M, Bressler NM, Beck RW, Chan CK, Grover S, Miller DG> ;JAMA Ophthalmol. 2013 Aug
13 citations
A Half Century of Burn Epidemiology and Burn Care in a Rural State
Laura L. Blaisdell, Reeve Chace, Lee D. Hallagan, David E. Clark> ;Journal of Burn Care & Research. 2012 May 1
Comparison of film and digital fundus photographs in eyes of individuals with diabetes mellitus.
Gangaputra S, Almukhtar T, Glassman AR, Aiello LP, Bressler N, Bressler SB, Danis RP, Davis MD> ;Invest Ophthalmol Vis Sci. 2011 Aug 03
Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema.
Elman MJ, Aiello LP, Beck RW, Bressler NM, Bressler SB, Edwards AR, Ferris FL 3rd, Friedman SM, Glassman AR, Miller KM, Scott IU, Stockdale CR, Sun JK> ;Ophthalmology. 2010 Jun
Optical coherence tomography measurements and analysis methods in optical coherence tomography studies of diabetic macular edema.
Browning DJ, Glassman AR, Aiello LP, Bressler NM, Bressler SB, Danis RP, Davis MD, Ferris FL, Huang SS, Kaiser PK, Kollman C, Sadda S, Scott IU, Qin H> ;Ophthalmology. 2008 Aug
7 citations
Retinal artery occlusion due to moyamoya disease.
R Chace, T R Hedges rd> ;Journal of Clinical Neuro-Ophthalmology. 1984 Mar 1
The same, but oh so different.
Chace R> ;Rhode Island Medical Journal. 1979 May 1
26 citations
A Comparison of Bacterial Plaque Disclosants in Periodontal Disease
D. Walter Cohen, Norman H. Stoller, Richard Chace, Larry Laster> ;Journal of Periodontology. 1972 Jun 1
Join now to see all

Journal Articles

Combination verteporfin photodynamic therapy ranibizumab-dexamethasone in choroidal neovascularization due to age-related macular degenration results of a phase II ran...
Gallemore RP, Wallsh J, Hudson HL, Ho AC, Chace R, Pearlman J, Clin Opthalmol, 1/24/2017
Sustained delivery fluocinolone acetonide vitreous implants, long term benefits in patients with chronic diabetic macular edema
Cunha-Vaz J, Ashton P, Iezzi R, Campochiaro P, Dugel PU, Holz FG, Weber M, Danis RP, Kuppermann BD, Bailey C, Billman K, Kapik B, Kane F, Green K, Chace R; FAME Study ..., Ophthalmology, 1/1/2014

Press Mentions

Effect of Initial Management with Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients with Diabetic Macular Edema Involving the Center of the Macula and Good Visual AcuityMay 1st, 2019